Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Irene M. Hutchins"'
Publikováno v:
Translational Cancer Research. 6:109-116
Therapeutic approaches in multiple myeloma (MM) are increasingly focused on restoring antitumor immunity. Immunomodulators have a variety of effects on the immune microenvironment, and are frequently incorporated into multidrug regimens. The monoclon
Autor:
Richard E. Latchaw, Krista Keachie, Karen A. Smith, Irene M. Hutchins, Nancy Rudisill, Lori Kennedy Madden, Karen A. Ko, Kiarash Shahlaie, J. Paul Muizelaar
Publikováno v:
Journal of Neurosurgery. 115:602-611
Object Posttraumatic vasospasm (PTV) is an underrecognized cause of ischemic damage after severe traumatic brain injury (TBI) that independently predicts poor outcome. There are, however, no guidelines for PTV screening and management, partly due to
Autor:
Michael Tanaka, W. S. Holland, Irene M. Hutchins, Primo N. Lara, Edward J. Kim, Rebekah A. Burich, Leslie Snyder-Solis, Afsaneh Barzi, I-Yeh Gong, Heinz-Josef Lenz, Laurel A. Beckett, Thomas J. Semrad, Philip C. Mack
Publikováno v:
Semrad, T; Barzi, A; Lenz, HJ; Hutchins, IM; Kim, EJ; Gong, IY; et al.(2014). Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results. International Journal of Clinical Oncology. doi: 10.1007/s10147-014-0730-2. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/45088889
International journal of clinical oncology, vol 20, iss 3
International journal of clinical oncology, vol 20, iss 3
Purpose Erlotinib marginally improves survival when administered continuously with gemcitabine to patients with advanced pancreatic cancer; however, preclinical data suggest that there is antagonism between chemotherapy and epidermal growth factor re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd551d341204a2a9dd26a97a6238a058
https://europepmc.org/articles/PMC4318776/
https://europepmc.org/articles/PMC4318776/
Autor:
Jill Waalen, Carrie Costantini, Marin Xavier, Levanto Schachter, Jeffrey Andrey, Irene M. Hutchins, Giovanni Paternostro, Carol Burian, Darren Finlay, James R. Mason, William E. Miller, Kristiina Vuori
Publikováno v:
Blood. 128:5208-5208
Introduction: Acute myeloid leukemia (AML) remains a challenging malignancy to treat, with high mortality despite recent advances in cancer care. The mainstay of therapy is intensive chemotherapy including anthracyclines and antimetabolites, with or
Autor:
Kiarash, Shahlaie, Krista, Keachie, Irene M, Hutchins, Nancy, Rudisill, Lori K, Madden, Karen A, Smith, Karen A, Ko, Richard E, Latchaw, J Paul, Muizelaar
Publikováno v:
Journal of neurosurgery. 115(3)
Posttraumatic vasospasm (PTV) is an underrecognized cause of ischemic damage after severe traumatic brain injury (TBI) that independently predicts poor outcome. There are, however, no guidelines for PTV screening and management, partly due to limited
Autor:
Clifford G. Tepper, Thomas J. Semrad, Irene M. Hutchins, Philip C. Mack, Stephenie Liu, Ryan R. Davis, Rebekah Tsai
Publikováno v:
Cancer Research. 75:5242-5242
Pancreatic cancer is a uniquely lethal malignancy characterized by frequent mutations in KRAS, CDKN2A, SMAD4, TP53 and many other genes. Molecular characterization is complicated by relatively few patients presenting with surgically resectable diseas